RELMADA THERAPEUTICS, INC. (RLMD) Net income 2016–2025
RELMADA THERAPEUTICS, INC. (RLMD) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$57.4MFY2025 · since FY2016: -$6.3M → -$57.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$57.4M | +28.3% |
| FY2024 | -$80.0M | +19.0% |
| FY2023 | -$98.8M | +37.1% |
| FY2022 | -$157.0M | -24.9% |
| FY2021 | -$125.8M | -111.5% |
| FY2020 | -$59.5M | -296.2% |
| FY2019 | -$15.0M | +13.4% |
| FY2018 | -$17.3M | -93.3% |
| FY2017 | -$9.0M | -42.5% |
| FY2016 | -$6.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More RLMD financial trends
RLMD RevenueRLMD Net marginRLMD Gross profitRLMD Gross marginRLMD Operating incomeRLMD Operating marginRLMD Operating cash flowRLMD Free cash flowRLMD Capital expendituresRLMD Return on equityRLMD Stock buybacksRLMD Dividends paidRLMD Total assetsRLMD Total liabilitiesRLMD Shareholders’ equityRLMD overview →